Transfusion requirements in patients with dengue hemorrhagic fever

Transfusion requirements in patients with dengue hemorrhagic fever

Dengue viruses are endemic in Thailand and Southeast Asian countries. A retrospective study of 175 patients with dengue virus infection admitted at the Department of Pediatrics, Ramathibodi Hospital in 1997 was carried out. Fifteen and 160 patients were clinically diagnosed with dengue fever and den...

Full description

Saved in:
Bibliographic Details
Published in:Southeast Asian journal of tropical medicine and public health Vol. 31; no. 1; pp. 10 - 14
Main Authors: CHUANSUMRIT, Ampaiwan, PHIMOLTHARES, Vawdaw, TARDTONG, Pimpan, TAPANEYA-OLARN, Chaleomsri, TAPANEYA-OLARN, Wiwat, KOWSATHIT, Pongsakdi, CHANTAROJSIRI, Teerachai
Format: Journal Article
Language:English
Published: Bangkok Southeast Asian Ministers of Education Organization, Regional Tropical Medicine and Public Health Network 01-03-2000
Subjects:
Adolescent
Arboviroses
Biological and medical sciences
Blood Transfusion
Child
Child, Preschool
Dengue fevers
Female
Gastrointestinal Hemorrhage - etiology
Gastrointestinal Hemorrhage - therapy
Hemorrhage - etiology
Hemorrhage - therapy
Human viral diseases
Humans
Infant
Infectious diseases
Male
Medical sciences
Platelet Count
Retrospective Studies
Severe Dengue - blood
Severe Dengue - complications
Severe Dengue - therapy
Tropical medicine
Tropical viral diseases
Viral diseases
Thailand
Asia
Infection
Human
Hemorrhagic fever
Treatment
Transfusion
Dengue hemorrhagic fever
Dengue
Viral disease
Arbovirus disease
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dengue viruses are endemic in Thailand and Southeast Asian countries. A retrospective study of 175 patients with dengue virus infection admitted at the Department of Pediatrics, Ramathibodi Hospital in 1997 was carried out. Fifteen and 160 patients were clinically diagnosed with dengue fever and dengue hemorrhagic fever (DHF), respectively. DHF was commonly found in patients whose ages ranged from 10 to 14 years. The mean body weight was at the 54th percentile for age. In the management, 10.6% of patients with DHF required blood component therapy which included platelet concentrate (64.7%) in patients who exhibited active bleeding, packed red cells (47%) in patients who exhibited a rapid drop in the hematocrit and fresh frozen plasma (29.4%) in patients with circulatory failure who did not respond to intravenous fluid. The transfusion requirement was significantly correlated with the occurrence of bleeding (p < 0.008) and bleeding in the gastrointestinal tract (p < 0.0001) but not correlated with the number of platelet counts (p = 0.207). As a result, physicians in charge should be aware of the transfusion requirement and communicate this to the blood bank in advance for the preparation of appropriate blood components.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0125-1562